Molecular determinants of heart failure with normal left ventricular ejection fraction

Pharmacological Reports

Volumn 61, Issue 1, 2009, Pages 139-145

  Borbély, Attila ^a,b   Papp, Zoltán ^a   Édes, István ^a   Paulus, Walter J ^b  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Cardiomyocytes; Diabetes mellitus; Diastolic function; Fibrosis; Heart failure; Myofilamentary proteins

Indexed keywords

ACTIN; ADVANCED GLYCATION END PRODUCT; COLLAGEN; CONNECTIN; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC GMP DEPENDENT PROTEIN KINASE; CYCLOOXYGENASE 2; DESMIN; MYOSIN BINDING PROTEIN C; MYOSIN HEAVY CHAIN; NITRIC OXIDE; PHOSPHOLAMBAN; PROTEIN KINASE C; PROTEIN KINASE D; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; SODIUM CALCIUM EXCHANGE PROTEIN; TROPOMYOSIN; TROPONIN I; TROPONIN T;

CONFERENCE PAPER; DIABETES MELLITUS; DIASTOLIC DYSFUNCTION; ENZYME ACTIVATION; EXTRACELLULAR MATRIX; HEART FAILURE; HEART HEMODYNAMICS; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; HUMAN; MYOFILAMENT; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

EID: 66949125305     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/S1734-1140(09)70016-7     Document Type: Conference Paper

References (46)

1. Asbun J, Villarreal FJ: The pathogenesis of mocardial fbrosis in the setting of diabetic cardiomyopathy. J Am Coll Cardiol, 2006, 47, 693-700.
2. Bagi Z, Erdei N, Papp Z, Edes I, Koller A: Up-regulation of vascular cyclooxygenase-2 in diabetes mellitus. Pharmacol Rep, 2006, 58, Suppl, 52-56.
3. Baicu CF, Zile MR, Aurigemma GP, Gaasch WH: Left ventricular systolic performance, function, and contractility in patients with diastolic heart failure. Circulation, 2005, 111, 2306-2312.
4. ε-(carboxymethyl) lysine depositions in intramyocardial blood vessels in human and rat acute myocardial infarction: a predictor or reflection of infarction? Arterioscler Thromb Vasc Biol, 2006, 26, 2497-2503.
5. Bauersachs J, Widder JD: Endothelial dysfunction in heart failure. Pharmacol Rep, 2008, 60, 119-126.
6. Borbely A, van der Velden J, Papp Z, Bronzwaer JGF, Edes I, Stienen GJM, Paulus WJ: Cardiomyocyte stiffness in diastolic heart failure. Circulation, 2005, 111, 774-781.
7. Bronzwaer JGF, Heymes C, Visser CA, Paulus WJ: Myocardial fibrosis blunts nitric oxide synthase-related preload reserve in human dilated cardiomyopathy. Am J Physiol Heart Circ Physiol, 2003, 284, H10-H16.
8. Brownlee M: The pathobiology of diabetic complications: a unifying mechanism. Diabetes, 2005, 54, 1615-1625.
9. Calderone A, Takahashi N, Izzo NJ, Jr., Thaik CM, Colucci WS: Pressure- and volume-induced left ventricular hypertrophies are associated with distinct myocyte phenotypes and differential induction of peptide growth factor mRNAs. Circulation, 1995, 92, 2385-2390.
10. Chen HH, Lainchbury JG, Senni M, Bailey KR, Redfield MM: Diastolic heart failure in the community: clinical profile, natural history, therapy, and impact of proposed diagnostic criteria. J Card Fail, 2002, 8, 279-287.
11. Cleland JGF, Cohen-Solal A, Aguilar JC, Dietz R, Eastaugh J, Follath F, Freemantle N et al.: Management of heart failure in primary care (the IMPROVEMENT of Heart Failure Programme): an international survey. Lancet, 2002, 360, 1631-1639.
12. Diamant M, Lamb HJ, Groeneveld Y, Endert EL, Smit JWA, Bax JJ, Romijn JA et al.: Diastolic dysfunction is associated with altered myocardial metabolism in asymptomatic normotensive patients with well-controlled type 2 diabetes mellitus. J Am Coll Cardiol, 2003, 42, 328-335.
13. Diez J, Querejeta R, Lopez B, Gonzalez A, Larman M, Martinez Ubago JL: Losartan-dependent regression of myocardial fibrosis is associated with reduction of left ventricular chamber stiffness in hypertensive patients. Circulation, 2002, 105, 2512-2517.
14. Factor SM, Flomenbaum M, Zhao MJ, Eng C, Robinson TF: The effects of acutely increased ventricular cavity pressure on intrinsic myocardial connective tissue. J Am Coll Cardiol, 1988, 12, 1582-1589.
15. Fang ZY, Prins JB, Marwick TH: Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications. Endocr Rev, 2004, 25, 543-567.
16. Gerdes AM: Cardiac myocyte remodeling in hypertrophy and progression to failure. J Card Fail, 2002, 8, S264-S268.
17. Hasenfuss G, Pieske B: Calcium cycling in congestive heart failure. J Mol Cell Cardiol, 2002, 34, 951-969.
18. Ilercil A, Devereux RB, Roman MJ, Paranicas M, O'Grady MJ, Lee ET, Welty TK et al.: Associations of insulin levels with left ventricular structure and function in American Indians: the strong heart study. Diabetes, 2002, 51, 1543-1547.
19. Jain A, Avendano G, Dharamsey S, Dasmahapatra A, Agarwal R, Reddi A, Regan T: Left ventricular diastolic function in hypertension and role of plasma glucose and insulin. Comparison with diabetic heart. Circulation, 1996, 93, 1396-1402.
20. Kass DA, Bronzwaer JGF, Paulus WJ: What mechanisms underlie diastolic dysfunction in heart failure? Circ Res, 2004, 94, 1533-1542.
21. Katz AM, Zile MR: New molecular mechanism in diastolic heart failure. Circulation, 2006, 113, 1922-1925.
22. Kitzman DW: Diastolic heart failure in the elderly. Heart Fail Rev, 2002, 7, 17-27.
23. Klapholz M, Maurer M, Lowe AM, Messineo F, Meisner JS, Mitchell J, Kalman J et al.: Hospitalization for heart failure in the presence of a normal left ventricular ejection fraction: Results of the New York heart failure registry. J Am Coll Cardiol, 2004, 43, 1432-1438.
24. Kuwahara F, Kai H, Tokuda K, Kai M, Takeshita A, Egashira K, Imaziumi T: Transforming growth factor-β function blocking prevents myocardial fibrosis and diastolic dysfunction in pressure-overloaded rats. Circulation, 2002, 106, 130-135.
25. Lamberts RR, Willemsen MJJM, Perez NG, Sipkema P, Westerhof N: Acute and specific collagen type I degradation increases diastolic and developed tension in perfused rat papillary muscle. Am J Physiol Heart Circ Physiol, 2004, 286, H889-H894.
26. Linke WA, Popov VI, Pollack GH: Passive and active tension in single cardiac myofibrils. Biophys J, 1994, 67, 782-792.
27. MacKenna DA, Omens JH, McCulloch AD, Covell JW: Contribution of collagen matrix to passive left ventricular mechanics in isolated rat hearts. Am J Physiol Heart Circ Physiol, 1994, 266, H1007-H1018.
28. MacLennan DH, Kranias EG: Phospholamban: a crucial regulator of cardiac contractility. Nat Rev Mol Cell Biol, 2003, 4, 566-577.
29. Marks AR, Reiken S, Marx SO: Progression of heart failure: Is protein kinase A hyperphosphorylation of the ryanodine receptor a contributing factor? Circulation, 2002, 105, 272-275.
30. Masoudi FA, Havranek EP, Smith G, Fish RH, Steiner JF, Ordin DL, Krumholz HM: Gender, age, and heart failure with preserved left ventricular systolic function. J Am Coll Cardiol, 2003, 41, 217-223.
31. Matsumoto T, Wada A, Tsutamoto T, Ohnishi M, Isono T, Kinoshita M: Chymase inhibition prevents cardiac fibrosis and improves diastolic dysfunction in the progression of heart failure. Circulation, 2003, 107, 2555-2558.
32. Morris-Thurgood JA, Frenneaux MP: Diastolic ventricular interaction and ventricular diastolic filling. Heart Fail Rev, 2000, 5, 307-323.
33. Owan TE, Hodge DO, Herges RM, Jacobsen SJ, Roger VL, Redfield MM: Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med, 2006, 355, 251-259.
34. Pak PH, Maughan WL, Baughman KL, Kass DA: Marked discordance between dynamic and passive diastolic pressure-volume relations in idiopathic hypertrophic cardiomyopathy. Circulation, 1996, 94, 52-60.
35. Paulus WJ, Tschope C, Sanderson JE, Rusconi C, Flachskampf FA, Rademakers FE, Marino P et al.: How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. Eur Heart J, 2007, 28, 2539-2550.
36. Poornima IG, Parikh P, Shannon RP: Diabetic cardiomyopathy: the search for a unifying hypothesis. Circ Res, 2006, 98, 596-605.
37. Redfield MM: Understanding "diastolic" heart failure. N Engl J Med, 2004, 350, 1930-1931.
38. Vallbracht KB, Schwimmbeck PL, Kuhl U, Rauch U, Seeberg B, Schultheiss HP: Differential aspects of endothelial function of the coronary microcirculation considering myocardial virus persistence, endothelial activation, and myocardial leukocyte infiltrates. Circulation, 2005, 111, 1784-1791.
39. van Heerebeek L, Borbely A, Niessen HWM, Bronzwaer JGF, van der Velden J, Stienen GJM, Linke WA et al.: Myocardial structure and function differ in systolic and diastolic heart failure. Circulation, 2006, 113, 1966-1973.
40. van Heerebeek L, Hamdani N, Handoko ML, Falcao-Pires I, Musters RJ, Kupreishvili K, Ijsselmuiden AJ et al.: Diastolic stiffness of the failing diabetic heart: importance of fibrosis, advanced glycation end products, and myocyte resting tension. Circulation, 2008, 117, 43-51.
41. Weber CR, Piacentino V, III, Houser SR, Bers DM: Dynamic regulation of sodium/calcium exchange function in human heart failure. Circulation, 2003, 108, 2224-2229.
42. Yamasaki R, Wu Y, McNabb M, Greaser M, Labeit S, Granzier H: Protein kinase A phosphorylates titin's cardiac-specific N2B domain and reduces passive tension in rat cardiac myocytes. Circ Res, 2002, 90, 1181-1188.
43. Zieman SJ, Melenovsky V, Clattenburg L, Corretti MC, Capriotti A, Gerstenblith G, Kass DA: Advanced glycation end product crosslink breaker (alagebrium) improves endothelial function in patients with isolated systolic hypertension. J Hypertens, 2007, 25, 577-583.
44. Zile MR, Baicu CF, Bonnema DD: Diastolic heart failure: definitions and terminology. Prog Cardiovasc Dis, 2005, 47, 307-313.
45. Zile MR, Baicu CF, Gaasch WH: Diastolic heart failure - abnormalities in active relaxation and passive stiffness of the left ventricle. N Engl J Med, 2004, 350, 1953-1559.
46. Zile MR, Brutsaert DL: New concepts in diastolic dysfunction and diastolic heart failure: Part I: diagnosis, prognosis, and measurements of diastolic function. Circulation, 2002, 105, 1387-1393.